TUMMINELLO, Francesca Maria
TUMMINELLO, Francesca Maria
Giurisprudenza
Activin A and matrix metalloproteinase -2 and -9 blood levels as gauges of bone metastatic spread
2006-01-01 LETO G; INCORVAIA L; TUMMINELLO FM; FLANDINA C; CRESCIMANNO M; BADALAMENTI G
Activin A circulating levels in patients with bone metastasis from breast or prostate cancer
2006-01-01 LETO, G; INCORVAIA, L; BADALAMENTI, G; TUMMINELLO, FM; GEBBIA, N; FLANDINA, C; CRESCIMANNO, M; RINI, GB
Acute myocardial effects of mitoxantrone in the rabbit
1987-01-01 Tumminello F.M.; Leto G.; Gebbia N.; Russo A.; Rausa L.
Antimetastatic activity of adriamycin in combinations with proteinase inhibitors in mice
1990-01-01 Leto G.; Tumminello F.M.; Gebbia N.; Woynarowska B.; Bernacki R.J.
Cathepsin D activity levels in colorectal cancer: Correlation with cathepsin B and L and other biological and clinical parameters
1994-01-01 Leto G.; Tumminello F.M.; Russo A.; Pizzolanti G.; Bazan V.; Gebbia N.
Cathepsin D content in colorectal cancer
1995-01-01 Tumminello F.M.; Gebbia N.; Pizzolanti G.; Russo A.; Bazan V.; Leto G.
Cathepsin D expression levels in nongynecological solid tumors: Clinical and therapeutic implications
2004-01-01 LETO, G; TUMMINELLO, FM; CRESCIMANNO, M; FLANDINA, C; GEBBIA, N
Cathepsin D in the malignant progression of neoplastic diseases
1992-01-01 Leto G.; Gebbia N.; Rausa L.; Tumminello F.M.
Cathepsin D Serum Mass Concentrations in Patients with Hepatocellular Carcinoma and/or Liver Cirrhosis
1996-01-01 Leto G.; Tumminello F.M.; Pizzolanli G.; Gebbia N.; Montalto G.; Soresi M.; Ruggeri I.
Cathepsin D, B and L circulating levels as prognostic markers of malignant progression
1996-01-01 Tumminello F.M.; Leto G.; Pizzolanti G.; Candiloro V.; Crescimanno M.; Crosta L.; Flandina C.; Montalto G.; Soresi M.; Carroccio A.; Bascone F.; Ruggeri I.; Ippolito S.; Gebbia N.
Cathepsin D: A possible biochemical marker for anthracycline cardiomyopathy
1987-01-01 Leto G.; Tumminello F.M.; Gebbia N.; Farruggia P.; Rausa L.
Cathepsin L in metastatic bone disease: therapeutic implications
2010-01-01 Leto, G; Sepporta, MV; Crescimanno, M; Flandina, C; Tumminello, FM
Cathepsin L in normal and pathological bone reodeling
2011-01-01 Leto, G; Crescimanno, M; Flandina, C; Sepporta, MV; Tumminello, FM
Circulating cathepsin K and cystatin C in patients with cancer related bone disease: Clinical and therapeutic implications
2007-01-01 TUMMINELLO, FM; FLANDINA, C; CRESCIMANNO, M; LETO, G
Cytotoxic effects of a crude extract of extra virgin olive oil on human HL60 cell lines sensitive and resistant with MDR phenotype
2008-01-01 SEPPORTA MV; LETO G; FLANDINA C; TUMMINELLO FM; GIAMMANCO M; DI MAJO D; TOLOMEO M; CRESCIMANNO M
Cytotoxic effects of polyphenols from waste-water of extra virgin olive oil on human HL60 and K562 cell lines.
2009-01-01 Sepporta, MV; Leto, G; Flandina, C; Tumminello, FM; La Guardia, M; Giammanco, M; Di Majo, D; Tolomeo, M; Crescimanno, M
Differential expression levels of urokinase-type plasminogen activator and cathepsin D in locally advanced laryngeal squamous cell carcinoma: Clinical implications
2001-01-01 Leto G.; Tumminello F.M.; Gebbia N.; Bazan V.; Tomasino R.M.; Dardanoni G.; Russo A.
Effect of extra virgin olive oli phenols on HL60 cell lines sensitive and resistant to anthracyclines
2009-01-01 Crescimanno, M; Sepporta, MV; Tripoli, E; Flandina, C; Giammanco, M; Tumminello, FM; Di Majo, D; Tolomeo, M; La Guardia, M; Leto, G
Effects of amsacrine (m-AMSA) a new aminoacridine antitumor drug, on the rabbit heart
1983-01-01 D'Alessandro N.; Gebbia N.; Crescimanno M.; Flandina C.; Leto G.; Tumminello F.M.; Messina L.
Effects of E-64 (cysteine-proteinase inhibitor) and Pepstatin (aspartyl-proteinase inhibitor) on metastasis formation in mice with mammary and ovarian tumors
1994-01-01 Leto G.; Pizzolanti G.; Tumminello F.M.; Gebbia N.